CAMG Solamere Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,743
Closed -$214K 92
2020
Q4
$214K Sell
2,743
-19,812
-88% -$1.52M 0.18% 94
2020
Q3
$1.78M Hold
22,555
1% 34
2020
Q2
$1.67M Sell
22,555
-1,120
-5% -$84.3K 0.92% 42
2020
Q1
$1.74M Buy
+23,675
New +$1.86M 0.91% 42
2017
Q4
Sell
-31,660
Closed -$1.93M 139
2017
Q3
$1.93M Buy
31,660
+6,857
+28% +$416K 0.97% 40
2017
Q2
$1.52M Buy
24,803
+1,762
+8% +$107K 0.87% 42
2017
Q1
$1.4M Buy
23,041
+9,001
+64% +$546K 0.82% 47
2016
Q4
$789K Buy
+14,040
New +$822K 0.56% 65

Other funds holding MRK

CAMG Solamere Management's MRK Position: Q1 2021 in Review

CAMG Solamere Management sold out of Merck (MRK) in Q1 2021, closing a stake of 2,743 shares — an estimated $214K sold.

CAMG Solamere Management first reported a position in MRK in Q4 2016 and held it in 8 quarters. The position peaked at $1.93M in Q3 2017. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • CAMG Solamere Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • CAMG Solamere Management sold 2,743 Merck shares in Q1 2021, an estimated $214K.
  • CAMG Solamere Management first reported a position in Merck in Q4 2016 and held it in 8 quarters.
  • CAMG Solamere Management's Merck position peaked at $1.93M in Q3 2017.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on CAMG Solamere Management's 13F filing for Q1 2021, filed 17 May 2021.